Locations
Newton, MA, USA · Newton, NJ, USA
industry
Biotechnology · Biotechnology Research · Health Care · Medical · Therapeutics
Size
11 - 50 employees
Stage
Other
founded in
2015
About

Abcuro is a biotechnology company developing antibody-based therapies targeting highly cytotoxic T cells involved in autoimmune diseases. Its pipeline includes Ulviprubart, an investigational monoclonal antibody for inclusion body myositis and other autoimmune disorders.

Something looks off?
Open jobs at Abcuro
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.